Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

<ul><li><keyword id="6409874" type="COMPANY" weightage="20" keywordseo="astrazeneca">AstraZeneca</keyword> has announced that it will be testing different combinations of the COVID-19 vaccine with Russia’s Gamaleya Institute, which is developing the <keyword id="9739494" type="UNKNOWN" weightage="20" keywordseo="sputnik-v-vaccine">Sputnik V vaccine</keyword>. </li><li>This comes after the UK government said that AstraZeneca will be conducting a ‘mix and match’ trial with Pfizer’s COVID-19 vaccine candidate starting January 2021.</li><li>According to AstraZeneca, testing out different vaccine combinations gives patients and doctors a wider choice of prevention approaches. </li></ul>AstraZeneca, which is currently developing a COVID-19 vaccine with Oxford University, has announced plans to test different vaccine combinations with the Gamaleya Institute. They are the developers behind Russia’s Sputnik V vaccine. <div type="Article" hostid="261" msid="79365393" title="Oxford and AstraZeneca COVID-19 vaccine is 70% effective — India may authorise emergency use after UK nod" mstype="2" mssubtype="0"></div> This comes after the head of the UK’s vaccine taskforce Kate Bingham <a href="https://www.businessinsider.in/science/health/news/the-pfizer-and-astrazeneca-covid-19-shots-will-be-combined-in-a-mix-and-match-trial-to-see-if-the-2-vaccines-together-produce-a-stronger-immune-response/articleshow/79625869.cms">announced</a> another ‘mix and match’ trial between <keyword id="10415855" type="UNKNOWN" weightage="20" keywordseo="astrazeneca-and-pfizer">AstraZeneca and Pfizer</keyword>’s COVID-19 vaccines earlier this week. The trial will test whether combining the doses from developers would work better than administering them individually. The push on combining different COVID-19 vaccine stems from the fact they could potentially provide patients and doctors with a wider choice of prevention approaches, according to <a href="https://www.astrazeneca.ru/content/az-ru/media/news/2020/20201211-ru201.html">AstraZeneca</a>. Meanwhile, the vaccine being developed by AstraZeneca and Oxford University is yet to get approval from regulatory authorities for emergency use, including India. <div type="Article" hostid="261" msid="79371741" title="The Oxford COVID-19 vaccine will only cost the Indian government $3 per dose, reveals Adar Poonawalla" mstype="2" mssubtype="0"></div> Sputnik V-AstraZeneca COVID-19 vaccine combinations Russia’s Gamaleya Institute had reached out to AstraZeneca on Twitter last month to ask whether the two should come together to try and boost the vaccine’s effectiveness. Enrollment for the Sputnik V-AstraZeneca clinical trials will kick-off <a href="https://www.astrazeneca.ru/content/az-ru/media/news/2020/20201211-ru201.html">starting today</a>. The Russian Direct Investment Fund, the county’s sovereign wealth fund which has funded the development of Sputnik V, believes that testing of the AstraZeneca’s vaccine in combination with its own will begin by the end of the month. This is around the same time that the Pfizer-AstraZeneca combination trials also expected to occur. The patients will receive one dose of the <keyword id="9655003" type="UNKNOWN" weightage="20" keywordseo="pfizer-vaccine">Pfizer vaccine</keyword> and another shot of the vaccine being made by AstraZeneca. “Being able to combine different COVID-19 vaccines may be helpful to improved protection and/or to improve vaccine accessibility. This is why it is important to explore different vaccine combinations to help make immunisation programmes more flexible, by allowing physicians greater choice at the time of administering vaccines,” the company said in a statement. In India, the COVID-19 vaccine being developed by AstraZeneca and Oxford University will be manufactured by the Serum Institute of India. It’s the preferred vaccine candidate as compared to Pfizer and Moderna due to its ability to survive in warmer temperatures, putting less of a strain on India’s limited cold storage infrastructure. SEE ALSO: <a href="https://www.businessinsider.in/science/environment/news/carbon-emissions-in-india-show-third-highest-drop-after-us-and-europe-in-2020-thanks-to-covid-19-lockdowns/articleshow/79673023.cms">Carbon emissions in India show third-highest drop after US and Europe in 2020 — thanks to COVID-19 lockdowns</a> <a href="https://www.businessinsider.in/science/environment/news/new-species-are-more-likely-to-emerge-in-extreme-environment-coldspots-rather-than-hotspots-like-the-amazon-rainforest/articleshow/79665428.cms">New species are more likely to emerge in extreme environment ‘coldspots’ rather than ‘hotspots’ like the Amazon rainforest</a> <a href="https://www.businessinsider.in/science/environment/news/as-rare-as-a-unicorn-a-new-horse-sized-species-of-the-beaked-whale-spotted-off-the-coast-of-mexico/articleshow/79665103.cms">As rare as a ‘unicorn’ — a new horse-sized species of the beaked whale spotted off the coast of Mexico</a>

After Pfizer, AstraZeneca plans to test COVID-19 vaccine combinations with Russia’s Sputnik V developers

<ul class="summary-list"><li><keyword id="6358826" type="LOCATION" weightage="60" keywordseo="Russia">Russia</keyword> wants 700 million people to be vaccinated with <keyword id="9739267" type="UNKNOWN" weightage="60" keywordseo="Sputnik-V">Sputnik V</keyword> this year, a top official said.</li><li>India, China, and South Korea will be the biggest producers, the CEO of the Russian Direct Investment fund said.</li><li>Russia's <keyword id="541062" type="PERSON" weightage="60" keywordseo="Sputnik">Sputnik</keyword> <keyword id="8763838" type="UNKNOWN" weightage="60" keywordseo="covid-19">COVID-19</keyword> <keyword id="24209" type="PERSON" weightage="60" keywordseo="vaccine">vaccine</keyword> has been approved in more than 40 countries so far.</li></ul>Russia plans to immunize nearly one in 10 people on the planet this year with its Sputnik V vaccine, a top official said."We have capacity to provide the vaccine to 700 million people outside Russia this year," Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF), <a href="https://www.bloomberg.com/news/articles/2021-03-12/russia-wants-to-vaccinate-nearly-1-in-10-on-the-planet-this-year?srnd=premium&amp;sref=lAVQtUwztUwz">told Bloomberg</a> Wednesday.The state-run fund, founded in 2011, supported the development of Sputnik V and is in charge of its roll-out to foreign countries."The biggest producers will be India, China, and South Korea," Dmitriev said, adding that the RDIF has production agreements in 10 countries.He said current output levels of the shot were "substantial," but Russia is banking on an "exponential growth" in domestic production to increase the number of shots.According to the <a href="https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/" target="_blank" title="More Than 326 Million Shots Given: Covid-19 Vaccine Tracker" rel="noopener">Bloomberg vaccine tracker</a>, more than 5 million people have been vaccinated with Russia's <keyword id="1754604" type="PERSON" weightage="60" keywordseo="coronavirus">coronavirus</keyword> vaccine, which studies suggest is <a href="https://www.businessinsider.com/russia-approved-coronavirus-vaccine-before-testing-safety-efficacy-2021-2">more than 90% effective</a>.Dmitriev told Bloomberg that between 40 and 50 million people around the world should get Sputnik V by late June. He didn't explain why demand for the shot would increase so quickly after that.Read more: <a href="https://www.businessinsider.com/niche-logistics-players-are-winning-big-in-vaccines-rollout-2021-3">Shipping the COVID-19 vaccines is creating huge business opportunities for previously unknown players - here are 10 companies that could become household names</a>So far, Russia's vaccine has been <a href="https://www.businessinsider.com/russia-sputnik-vaccine-40-countries-west-hoards-shots-2021-3">approved in more than 40 countries</a> across Latin America, Eastern Europe, Asia, and Africa. Many of these countries <a href="https://www.businessinsider.com/vaccine-wars-rich-countries-battle-doses-poorer-miss-out-2021-1">don't have access to the shots</a> made by Western firms such as Moderna and Pfizer.Dmitriev <a href="https://www.businessinsider.com/us-uk-approval-not-priority-russia-covid-19-vaccine-sputnik-v-2021-2">told Insider on February 2</a> that Sputnik V probably wouldn't be available in the US or UK in the near future. He said he was only moderately interested in sending it to <a href="https://www.businessinsider.com/vaccine-wars-eu-threatening-limit-exports-row-uk-astrazeneca-2021-1?r=US&amp;IR=TIR=T">Europe</a>.

Russia plans to vaccinate 1 in 10 people worldwide this year with the Sputnik vaccine, a top official said

You Searched For "sputnik covid 19 vaccine" and got 2 results

After Pfizer, AstraZeneca plans to test COVID-19 vaccine combinations with Russia’s Sputnik V developers

Prabhjote Gill

Russia plans to vaccinate 1 in 10 people worldwide this year with the Sputnik vaccine, a top official said

Kate Duffy

Popular Keywords

Buying Guides